NBC News: Oxford vaccine ‘protects against’ U.K. Covid-19 variant, trials suggest
Data indicates that the vaccine protects against the variant “which caused the surge in disease from the end of 2020 across the U.K.,” said Andrew Pollard.
AstraZeneca is still probably a month or two away from asking the FDA for approval. The company’s trials here in the United States are behind those in the United Kingdom.
